Clinical Trial Update: A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating high-dose, short-course levofloxacin for acute bacterial exacerbation of chronic bronchitis has completed. The update does not include …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• Levofloxacin (Levaquin) (Levofloxacin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bronchitis, Chronic Bronchitis | Phase 3 | Status: COMPLETED